Results 121 to 130 of about 2,396 (137)

Pembrolizumab for the treatment of programmed death–ligand 1‒positive advanced carcinoid or pancreatic neuroendocrine tumors: Results from the KEYNOTE‐028 study

Cancer, 2020
Janice M Mehnert, Bert H O'neil, Armando Santoro   +2 more
exaly  

A 5‐decade analysis of 13,715 carcinoid tumors

Cancer, 2003
Mark Kidd
exaly  

Frequency of carcinoid syndrome at neuroendocrine tumour diagnosis: a population-based study

Lancet Oncology, The, 2017
Daniel M Halperin, Chan Shen, Arvind Dasari   +2 more
exaly  

Integrative and comparative genomic analyses identify clinically relevant pulmonary carcinoid groups and unveil the supra-carcinoids

Nature Communications, 2019
Nicolas Alcala, Theo Giffon, Jules Derks
exaly  

Targeting Vascular Endothelial Growth Factor in Advanced Carcinoid Tumor: A Random Assignment Phase II Study of Depot Octreotide With Bevacizumab and Pegylated Interferon Alfa-2b

Journal of Clinical Oncology, 2008
Alexandria T Phan, Paulo M Hoff
exaly  

Phase II/III Study of Doxorubicin With Fluorouracil Compared With Streptozocin With Fluorouracil or Dacarbazine in the Treatment of Advanced Carcinoid Tumors: Eastern Cooperative Oncology Group Study E1281

Journal of Clinical Oncology, 2005
Stuart R Lipsitz
exaly  

One Hundred Years After “Carcinoid”: Epidemiology of and Prognostic Factors for Neuroendocrine Tumors in 35,825 Cases in the United States

Journal of Clinical Oncology, 2008
Alexandria T Phan
exaly  

A stepwise approach to the management of metastatic midgut carcinoid tumor

Nature Reviews Clinical Oncology, 2009
Sanjeev Bhattacharyya
exaly  

Staging of carcinoid tumours with 18F-DOPA PET: a prospective, diagnostic accuracy study

Lancet Oncology, The, 2006
Elisabeth G E De Vries, Philip H Elsinga, Pieter L Jager   +2 more
exaly  

Carcinoid Heart Disease

Circulation, 2007
Sanjeev Bhattacharyya
exaly